Impaired placentation is an important contributing factor to intra-uterine growth restriction
and pre-eclampsia in fetuses with congenital heart defects (CHD). These pregnancy …

It is established that neurodevelopmental disability (NDD) is common in neonates
undergoing complex surgery for congenital heart disease (CHD); however, the trajectory of …

Background The placenta is crucial for the overall development and lifelong health of the
fetus. Abnormal placental development and function occur in pregnancies with fetal …

The relationship between maternal risk factors (MRFs)(particularly pre-gravid obesity,
diabetes, and hypertension) and congenital heart disease (CHD) to placental and fetal brain …

Objective To evaluate corpus callosum (CC) size by neurosonography (NSG) in fetuses with
an isolated major congenital heart defect (CHD) and explore the association of CC size with …

Objectives To ascertain whether abnormalities in neonatal head circumference and/or body
weight are associated with levels of angiogenic/antiangiogenic factors in the maternal and …

Increasing recognition of the critical role of the pla-centa in the long-term health of the fetus
and mother has generated two important and evolving areas of research: the developmental …

Altered brain development has been highlighted as an important contributor to adverse
neurodevelopmental outcomes in children with congenital heart disease. Abnormalities …

Individuals born with congenital heart disease (CHD) are at an increased risk of developing
neurodevelopmental disorders. Despite this, studies are limited in their investigation of …

Background Vascular endothelial growth factor (VEGF) is a factor that is responsible for cell
proliferation, vascular endothelial cell growth, and angiogenesis. Changes in the level of this …